Rankings · Stocks

Best-performing Stocks

Compare investable companies across valuation, growth, quality, income and returns.

Latest complete snapshotSep 1, 2026
What the data shows

AT & S Austria Technologie & Systemtechnik AG (0O5C) is first on the displayed page, with +683.18% 1y in EUR. Returns in different listing currencies are not directly comparable.

Displayed results · 10 of 10 displayed price dates unavailable

Stock returns use each listing’s quoted currency. A combined distribution is omitted where currencies differ.

Ranks 11–20 · Full-universe context

1Y total return

Select a measure to rank the qualifying universe. The area locates the full ranked set.

A comparable full-universe distribution is unavailable for this measure. Different currencies or yield bases are not combined.

Stock performance rankings. Rankings use the selected methodology and latest complete published snapshot.
RankInstrumentClassificationRegionMarket cap1M*YTD*1Y*
11
0O5CAT & S Austria Technologie & Systemtechnik AGStock · Europe
StockEurope$2.3B+17.84%+381.62%+683.18%
12
PRAXPraxis Precision Medicines IncStock · North America
StockNorth America$9.6B+13.80%+18.85%+669.21%
13
FBRXForte Biosciences IncStock · North America
StockNorth America$1.6B+0.51%+182.32%+599.91%
14
SLSSellas Life Sciences Group IncStock · North America
StockNorth America$2.7B+33.27%+253.85%+594.79%
15
LITELumentum Holdings IncStock · North America
StockNorth America$84.2B+28.13%+148.18%+588.77%
16
IMMXImmix Biopharma IncStock · North America
StockNorth America$1B+68.63%+168.26%+531.98%
17
ORKAOruka Therapeutics, Inc.Stock · North America
StockNorth America$6B-4.03%+205.58%+525.81%
18
MRNAModerna IncStock · North America
StockNorth America$55.1B+156.00%+375.89%+482.57%
19
WDCWestern Digital CorporationStock · North America
StockNorth America$165.7B-17.31%+161.73%+462.32%
20
SYRESpyre Therapeutics Inc.Stock · North America
StockNorth America$8B-9.15%+172.68%+441.72%

Informational only. Rankings are not investment advice, a recommendation, or a prediction of future performance.